Exact Mass: 374.043

Exact Mass Matches: 374.043

Found 22 metabolites which its exact mass value is equals to given mass value 374.043, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

6-Hydroxymethyletoricoxib

{5-[5-chloro-3-(4-methanesulfonylphenyl)pyridin-2-yl]pyridin-2-yl}methanol

C18H15ClN2O3S (374.0492)


6-Hydroxymethyletoricoxib is only found in individuals that have used or taken Etoricoxib. 6-Hydroxymethyletoricoxib is a metabolite of Etoricoxib. 6-hydroxymethyletoricoxib belongs to the family of Bipyridines. These are organic compounds containing two pyridine rings linked to each other.

   

Etoricoxib 1'-N'-oxide

5-[5-chloro-3-(4-methanesulfonylphenyl)pyridin-2-yl]-2-methyl-1λ⁵-pyridin-1-one

C18H15ClN2O3S (374.0492)


Etoricoxib 1-N-oxide is a metabolite of etoricoxib. Etoricoxib (brand name NUSHIN MASCOT HEALTH SERIES Arcoxia worldwide; also Algix and Tauxib in Italy, Nucoxia in India) is a COX-2 selective inhibitor (approx. 106.0 times more selective for COX-2 inhibition over COX-1) from Merck & Co. Currently it is approved in more than 70 countries worldwide but not in the US, where the Food and Drug Administration (FDA) requires additional safety and efficacy data for etoricoxib before it will issue approval. (Wikipedia)

   

Iodopindolol

1-[(3-iodo-1H-indol-4-yl)oxy]-3-[(propan-2-yl)amino]propan-2-ol

C14H19IN2O2 (374.0491)


   

Maybridge4_004167

Maybridge4_004167

C20H16Cl2O3 (374.0476)


   
   

α,4-Dihydroxytriazolam

α,4-Dihydroxytriazolam

C17H12Cl2N4O2 (374.0337)


   

6-Hydroxymethyletoricoxib

{5-[5-chloro-3-(4-methanesulfonylphenyl)pyridin-2-yl]pyridin-2-yl}methanol

C18H15ClN2O3S (374.0492)


   

Magnesium Ascorbate

(+)-Magnesium L-ascorbate

C12H14MgO12 (374.0336)


D020011 - Protective Agents > D000975 - Antioxidants D018977 - Micronutrients > D014815 - Vitamins

   

ethene,3,3,4,4,5,5,6,6,6-nonafluorohex-1-ene,1,1,2,2-tetrafluoroethene

ethene,3,3,4,4,5,5,6,6,6-nonafluorohex-1-ene,1,1,2,2-tetrafluoroethene

C10H7F13 (374.034)


   
   

ammonium tungstate pentahydrate, 99.

ammonium tungstate pentahydrate, 99.

H18N2O9W (374.0522)


   

ammonium tungstate pentahydrate

ammonium tungstate pentahydrate

H18N2O9W (374.0522)


   

Bis(norbornadiene)rhodium(I) tetrafluoroborate

Bis(norbornadiene)rhodium(I) tetrafluoroborate

C14H16BF4Rh (374.0336)


   

ethyl 5-iodo-2-(4-methylpiperazin-1-yl)benzoate

ethyl 5-iodo-2-(4-methylpiperazin-1-yl)benzoate

C14H19IN2O2 (374.0491)


   

ethyl 3-iodo-4-(4-methylpiperazin-1-yl)benzoate

ethyl 3-iodo-4-(4-methylpiperazin-1-yl)benzoate

C14H19IN2O2 (374.0491)


   

3-iodo-4-(4-propan-2-ylpiperazin-1-yl)benzoic acid

3-iodo-4-(4-propan-2-ylpiperazin-1-yl)benzoic acid

C14H19IN2O2 (374.0491)


   

4-[(4-ethylpiperazin-1-yl)methyl]-3-iodobenzoic acid

4-[(4-ethylpiperazin-1-yl)methyl]-3-iodobenzoic acid

C14H19IN2O2 (374.0491)


   

methyl 3-iodo-4-[(3-methylpiperazin-1-yl)methyl]benzoate

methyl 3-iodo-4-[(3-methylpiperazin-1-yl)methyl]benzoate

C14H19IN2O2 (374.0491)


   

N-[2-[[3-chloro-5-(triluoromethyl)pyridin-2-yl]methylsulanyl]ethyl]benzamide

N-[2-[[3-chloro-5-(triluoromethyl)pyridin-2-yl]methylsulanyl]ethyl]benzamide

C16H14ClF3N2OS (374.0467)


   

ethyl (2Z)-5-phenyl-2-(1,1,1-trifluoro-3-methoxy-3-oxopropan-2-ylidene)-1,3-oxathiole-4-carboxylate

ethyl (2Z)-5-phenyl-2-(1,1,1-trifluoro-3-methoxy-3-oxopropan-2-ylidene)-1,3-oxathiole-4-carboxylate

C16H13F3O5S (374.0436)


   

3-(3-bromophenyl)-2-(4-fluorophenyl)-5,6,7,7a-tetrahydro-3H-pyrrolo[1,2-c]imidazol-1-one

3-(3-bromophenyl)-2-(4-fluorophenyl)-5,6,7,7a-tetrahydro-3H-pyrrolo[1,2-c]imidazol-1-one

C18H16BrFN2O (374.043)


   

Fatostatin (hydrobromide)

Fatostatin (hydrobromide)

C18H19BrN2S (374.0452)


Fatostatin hydrobromide (125B11 hydrobromide), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin hydrobromide binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin hydrobromide decreases the transcription of lipogenic genes in cells. Fatostatin hydrobromide possesses antitumor properties, and lowers hyperglycemia in ob/ob mice[1][2].